Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With Post-Transplant Cyclophosphamide (PTCy) As GVHD Prophylaxis In High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results